Showing results (1-10 of 109) with videos related to
Sort By:
Pageof 11
EMBO Molecular Medicine|January 6, 2010
Converting cancer mutations into therapeutic opportunitiesTom O'Brien, David StokoeExpert Reviews in Molecular Medicine|June 9, 2005
The phosphoinositide 3-kinase pathway and cancerDavid StokoeAngewandte Chemie (International Ed. in English)|March 5, 2014
Selective inhibition of mutant Ras protein through covalent bindingJoachim Rudolph, David StokoeBMC Medicine|July 3, 2010
Zinc finger nucleases as tools to understand and treat human diseasesDavid Davis, David StokoeThe Biochemical Journal|January 20, 2005
Direct comparison of the specificity of gene silencing using antisense oligonucleotides and RNAiBenoit Bilanges, David StokoeExpert Review of Neurotherapeutics|April 18, 2008
PTEN in brain tumorsDaphne Haas-Kogan, David StokoeFrontiers in Cell and Developmental Biology|June 8, 2026
Targeting NRF2 addiction in cancer: synthetic lethal strategies beyond direct inhibitionMelat T Gebru, David StokoeInternational Journal of Group Psychotherapy|September 25, 2015
Working at the Periphery: A View of Group Psychotherapy in AustraliaTom O'BrienCurrent Biology : CB|June 14, 2002
A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycleEmma Shtivelman, Joshua Sussman, David StokoePageof 11